VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL
Publication
, Conference
Peters, KB; Reardon, DA; Vredenburgh, JJ; Desjardins, A; Herndon, JE; Coan, A; McSherry, F; Lipp, E; Brickhouse, A; Massey, W; Friedman, HS
Published in: NEURO-ONCOLOGY
October 1, 2012
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2012
Volume
14
Start / End Page
81 / 81
Location
Washington, DC
Publisher
OXFORD UNIV PRESS INC
Conference Name
17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Peters, K. B., Reardon, D. A., Vredenburgh, J. J., Desjardins, A., Herndon, J. E., Coan, A., … Friedman, H. S. (2012). VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL. In NEURO-ONCOLOGY (Vol. 14, pp. 81–81). Washington, DC: OXFORD UNIV PRESS INC.
Peters, Katherine B., David A. Reardon, James J. Vredenburgh, Annick Desjardins, James E. Herndon, April Coan, Frances McSherry, et al. “VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL.” In NEURO-ONCOLOGY, 14:81–81. OXFORD UNIV PRESS INC, 2012.
Peters KB, Reardon DA, Vredenburgh JJ, Desjardins A, Herndon JE, Coan A, et al. VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2012. p. 81–81.
Peters, Katherine B., et al. “VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL.” NEURO-ONCOLOGY, vol. 14, OXFORD UNIV PRESS INC, 2012, pp. 81–81.
Peters KB, Reardon DA, Vredenburgh JJ, Desjardins A, Herndon JE, Coan A, McSherry F, Lipp E, Brickhouse A, Massey W, Friedman HS. VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2012. p. 81–81.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2012
Volume
14
Start / End Page
81 / 81
Location
Washington, DC
Publisher
OXFORD UNIV PRESS INC
Conference Name
17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences